Nurix Therapeutics Inc
NASDAQ:NRIX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nurix Therapeutics Inc
NASDAQ:NRIX
|
US |
|
O
|
Opendoor Technologies Inc
F:25M
|
US |
|
Interparfums SA
PAR:ITP
|
FR |
|
A
|
Attendo AB (publ)
F:7AT
|
SE |
|
S
|
Sunrun Inc
XMUN:3S9
|
US |
|
S
|
SAM Engineering & Equipment (M) Bhd
KLSE:SAM
|
MY |
Intrinsic Value
Is NRIX undervalued or overvalued?
See the intrinsic value estimate for Nurix Therapeutics Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
NRIX looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with NRIX’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Nurix Therapeutics Does
Nurix Therapeutics is a drug discovery company focused on targeted protein degradation. It designs medicines that help the cell destroy specific disease-causing proteins instead of just blocking them. Its lead work centers on cancer and immune diseases, where the company is building drug candidates that can act on targets that are hard to reach with standard medicines.
- Headquarters
- United States of America US
- Employees
- 317
- IPO date
- Jul 24, 2020
Revenue & Expenses Breakdown
Nurix Therapeutics Inc
Earnings Waterfall
Nurix Therapeutics Inc
The intrinsic value for Nurix Therapeutics Inc (NRIX) under the Base Case is hidden USD.
Compared with the current market price of 25.225 USD, the stock appears hidden.